Overview
Pseudohypertrophic Myopathy, also known as Duchenne Muscular Dystrophy, is a genetic disorder caused by a mutation in the dystrophin gene. It is characterized by progressive weakness and muscle wasting. It is the most common form of muscular dystrophy, affecting 1 out of approximately 3500-5000 male newborns worldwide. Patients with Pseudohypertrophic Myopathy typically experience difficulty with walking and other physical activities, and experienced muscle contractures and joint deformities. Common symptoms of the condition include muscle weakness, fatigue, muscle wasting, and difficulty with walking, climbing stairs, and other physical activities. Treatment of Pseudohypertrophic Myopathy usually includes physical therapy, medication to manage the symptoms, and orthopedic surgery. Genetic counseling may also be beneficial in understanding the condition and risk factors. The abnormal gene is inherited, so genetic counseling can also be helpful in providing information to families. The prognosis is generally poor, but with early diagnosis and treatment, the progression of the disease can be slowed, and the patients lifespan extended.